Urinary Malondialdehyde Is Associated with Visceral Abdominal Obesity in Middle-Aged Men

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Lee, Sun Min ^a   Cho, Young Hye ^a   Lee, Sang Yeoup ^a   Jeong, Dong Wook ^a   Cho, A Ra ^a   Jeon, Jeong Suk ^a   Park, Eun Ju ^a   Kim, Yun Jin ^b   Lee, Jeong Gyu ^b   Yi, Yu Hyeon ^b   Tak, Young Jin ^b   Hwang, Hye Rim ^b   Lee, Seung Hun ^b   Han, Junehee ^a  

^a Pusan National University Yangsan Hospital   (South Korea)

^b Pusan National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; TRIACYLGLYCEROL; URIC ACID; BIOLOGICAL MARKER;

ABDOMINAL FAT; ABDOMINAL OBESITY; ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CARBOHYDRATE INTAKE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIETARY INTAKE; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT INTAKE; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLIC PARAMETERS; MIDDLE AGED; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN INTAKE; SAGITTAL ABDOMINAL DIAMETER; SMOKING; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; WAIST CIRCUMFERENCE; ANTHROPOMETRY; BLOOD; CROSS-SECTIONAL STUDY; METABOLISM; OXIDATIVE STRESS; REGRESSION ANALYSIS; URINE;

ADULT; ANTHROPOMETRY; BIOMARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MALONDIALDEHYDE; MIDDLE AGED; OBESITY; OBESITY, ABDOMINAL; OXIDATIVE STRESS; REGRESSION ANALYSIS; SMOKING; URIC ACID; WAIST CIRCUMFERENCE;

EID: 84946077702     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/524291     Document Type: Article

References (33)

1. J. B. Meigs, P. W. F. Wilson, C. S. Fox et al., "Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease, " Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 8, pp. 2906-2912, 2006.
2. P. W. Wilson, R. B. D'Agostino, L. Sullivan, H. Parise, and W. B. Kannel, "Overweight and obesity as determinants of cardiovascular risk: the framingham experience, " Archives of Internal Medicine, vol. 162, no. 16, p. 1867, 2002.
3. A. Hiuge-Shimizu, K. Kishida, T. Funahashi et al., "Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in largescale Japanese general population (the VACATION-J study), " Annals of Medicine, vol. 44, no. 1, pp. 82-92, 2012.
4. K. Kishida, T. Funahashi, and I. Shimomura, "Clinical importance of assessment of type 2 diabetes mellitus with visceral obesity. A Japanese perspective, " Current Diabetes Reviews, vol. 8, no. 2, pp. 84-91, 2012.
5. Y.-W. Park, D. B. Allison, S. B. Heymsfield, and D. Gallagher, "Larger amounts of visceral adipose tissue in Asian Americans, " Obesity Research, vol. 9, no. 7, pp. 381-387, 2001.
6. C. M. Khoo, S. Sairazi, S. Taslim et al., "Ethnicity modifies the relationships of insulin resistance, inflammation, and adiponectin with obesity in a multiethnic Asian population, " Diabetes Care, vol. 34, no. 5, pp. 1120-1126, 2011.
7. G. Marchesini, M. Brizi, G. Blanchi et al., "Nonalcoholic fatty liver disease: A feature of the metabolic syndrome, " Diabetes, vol. 50, no. 8, pp. 1844-1850, 2001.
8. J. G. Lee, S. Lee, Y. J. Kim et al., "Multiple biomarkers and their relative contributions to identifying metabolic syndrome, " Clinica Chimica Acta, vol. 408, no. 1-2, pp. 50-55, 2009.
9. A. Onat, H. Uyarel, G. Hergenc et al., "Serum uric acid is a determinant of metabolic syndrome in a population-based study, " American Journal of Hypertension, vol. 19, no. 10, pp. 1055-1062, 2006.
10. M. K. Rutter, J. B. Meigs, L. M. Sullivan, R. B. D'Agostino Sr., and P. W. F. Wilson, "C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the framingham offspring study, " Circulation, vol. 110, no. 4, pp. 380-385, 2004.
11. H. Sies, "Biochemistry of oxidative stress, " Angewandte Chemie-International Edition in English, vol. 25, no. 12, pp. 1058-1071, 1986.
12. S. Furukawa, T. Fujita, M. Shimabukuro et al., "Increased oxidative stress in obesity and its impact on metabolic syndrome, " Journal of Clinical Investigation, vol. 114, no. 12, pp. 1752-1761, 2004.
13. J. F. Keaney Jr., M. G. Larson, R. S. Vasan et al., "Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the framingham study, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 3, pp. 434-439, 2003.
14. S. O. Olusi, "Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans, " International Journal of Obesity, vol. 26, no. 9, pp. 1159-1164, 2002.
15. J.-M. Fernández-Real, M. Broch, J. Vendrell, and W. Ricart, "Insulin resistance, inflammation, and serumfatty acid composition, " Diabetes Care, vol. 26, no. 5, pp. 1362-1368, 2003.
16. I. Saito, K. Yonemasu, and F. Inami, "Association of body mass index, body fat, and weight gain with inflammation markers among rural residents in Japan, " Circulation Journal, vol. 67, no. 4, pp. 323-329, 2003.
17. G. Dav?, M. T. Guagnano, G. Ciabattoni et al., "Platelet activation in obese women: role of inflammation and oxidant stress, " Journal of the AmericanMedical Association, vol. 288, no. 16, pp. 2008-2014, 2002.
18. D. Aronson and E. J. Rayfield, "How hyperglycemia promotes atherosclerosis: molecular mechanisms, " Cardiovascular Diabetology, vol. 1, article 1, 2002.
19. H. K. Vincent, S. K. Powers, A. J. Dirks, and P. J. Scarpace, "Mechanism for obesity-induced increase in myocardial lipid peroxidation, " International Journal of Obesity, vol. 25, no. 3, pp. 378-388, 2001.
20. P. Wallström, E. Wirfält, P. H. Lahmann, B. Gullberg, L. Janzon, and G. Berglund, "Serum concentrations of -carotene and -tocopherol are associated with diet, smoking, and general and central adiposity, " American Journal of Clinical Nutrition, vol. 73, no. 4, pp. 777-785, 2001.
21. A. A. Horton, S. Fairhurst, and J. S. Bus, "Lipid peroxidation and mechanisms of toxicity, " Critical Reviews in Toxicology, vol. 18, no. 1, pp. 27-79, 1987.
22. E. Seljeskog, T. Hervig, and M. A. Mansoor, "A novel HPLC method for the measurement of thiobarbituric acid reactive substances (TBARS). A comparison with a commercially available kit, " Clinical Biochemistry, vol. 39, no. 9, pp. 947-954, 2006.
23. U. Risérus, J. Ärnlöv, K. Brismar, B. Zethelius, L. Berglund, and B. Vessby, "Sagittal abdominal diameter is a strong anthropometric marker of insulin resistance and hyperproinsulinemia in obese men, " Diabetes Care, vol. 27, no. 8, pp. 2041-2046, 2004.
24. B.-K. Lee and Y. Kim, "Iron deficiency is associated with increased levels of blood cadmium in the Korean general population: analysis of 2008-2009 Korean National Health and Nutrition Examination Survey data, " Environmental Research, vol. 112, pp. 155-163, 2012.
25. S. Lee, H. K. Park, S. P. Son, C. W. Lee, I. J. Kim, and H. J. Kim, "Effects of oral magnesium supplementation on insulin sensitivity and blood pressure in normo-magnesemic nondiabetic overweight Korean adults, " Nutrition, Metabolism &Cardiovascular Diseases, vol. 19, no. 11, pp. 781-788, 2009.
26. C. L. Craig, A. L. Marshall, M. Sjöström et al., "International physical activity questionnaire: 12-country reliability and validity, " Medicine and Science in Sports and Exercise, vol. 35, no. 8, pp. 1381-1395, 2003.
27. R. Mendes, C. Cardoso, and C. Pestana, "Measurement of malondialdehyde in fish: a comparison study between HPLC methods and the traditional spectrophotometric test, " Food Chemistry, vol. 112, no. 4, pp. 1038-1045, 2009.
28. J. Lykkesfeldt, "Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking, " Clinica Chimica Acta, vol. 380, no. 1-2, pp. 50-58, 2007.
29. Y. Jang, O. Y. Kim, H. J. Ryu et al., "Visceral fat accumulation determines postprandial lipemic response, lipid peroxidation, DNA damage, and endothelial dysfunction in nonobese Korean men, " Journal of Lipid Research, vol. 44, no. 12, pp. 2356-2364, 2003.
30. I. Lemieux, A. Pascot, D. Prud'homme et al., "Elevated Creactive protein: another component of the atherothrombotic profile of abdominal obesity, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 6, pp. 961-967, 2001.
31. A. Cartier, M. Côté, I. Lemieux et al., "Age-related differences in inflammatory markers in men: contribution of visceral adiposity, " Metabolism, vol. 58, no. 10, pp. 1452-1458, 2009.
32. G. Block, M. Dietrich, E. P. Norkus et al., "Factors associated with oxidative stress in human populations, " American Journal of Epidemiology, vol. 156, no. 3, pp. 274-285, 2002.
33. F. Ozguner, A. Koyu, and G. Cesur, "Active smoking causes oxidative stress and decreases blood melatonin levels, " Toxicology and Industrial Health, vol. 21, no. 1-2, pp. 21-26, 2005.